Impact of COVID-19 Outbreak on Antibacterial Therapeutic, Global and China Market Size, Status and Forecast 2020-2026

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Antibacterial Therapeutic Revenue

1.4 Market Analysis by Type

1.4.1 Global Antibacterial Therapeutic Market Size Growth Rate by Type: 2020 VS 2026

1.4.2 Penicillins

1.4.3 Cephalosporins

1.4.4 Quinolone

1.4.5 Aminoglycosides

1.4.6 Monobactams

1.4.7 Carbapenems

1.4.8 Macrolides

1.4.9 Others

1.5 Market by Application

1.5.1 Global Antibacterial Therapeutic Market Size Growth Rate by Application: 2020 VS 2026

1.5.2 Oral

1.5.3 Topical

1.5.4 Parenteral

1.5.5 Others

1.6 Coronavirus Disease 2019 (Covid-19): Antibacterial Therapeutic Industry Impact

1.6.1 How the Covid-19 is Affecting the Antibacterial Therapeutic Industry

1.6.1.1 Antibacterial Therapeutic Business Impact Assessment - Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.6.2 Market Trends and Antibacterial Therapeutic Potential Opportunities in the COVID-19 Landscape

1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Antibacterial Therapeutic Players to Combat Covid-19 Impact

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trend

2.1 Global Antibacterial Therapeutic Market Perspective (2015-2026)

2.2 Antibacterial Therapeutic Growth Trends by Regions

2.2.1 Antibacterial Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026

2.2.2 Antibacterial Therapeutic Historic Market Size by Regions (2015-2020)

2.2.3 Antibacterial Therapeutic Forecasted Market Size by Regions (2021-2026)

2.2.4 Japan Antibacterial Therapeutic Market Share in Global Market 2015-2026

2.3 Industry Trends and Growth Strategy

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porter’s Five Forces Analysis

2.3.5 Antibacterial Therapeutic Market Growth Strategy

2.3.6 Primary Interviews with Key Antibacterial Therapeutic Players (Opinion Leaders)

3 Competitor Landscape by Key Players

3.1 Global Top Antibacterial Therapeutic Players by Market Size

3.1.1 Global Top Antibacterial Therapeutic Players by Revenue (2015-2020)

3.1.2 Global Antibacterial Therapeutic Revenue Market Share by Players (2015-2020)

3.1.3 Global Antibacterial Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.2 Global Antibacterial Therapeutic Market Concentration Ratio

3.2.1 Global Antibacterial Therapeutic Market Concentration Ratio (CR5 and HHI)

3.2.2 Global Top 5 and Top 10 Players by Antibacterial Therapeutic Revenue in 2019

3.3 Antibacterial Therapeutic Key Players Head office and Area Served

3.4 Key Players Antibacterial Therapeutic Product Solution and Service

3.5 Date of Enter into Antibacterial Therapeutic Market

3.6 Mergers & Acquisitions, Expansion Plans

4 Global Antibacterial Therapeutic Breakdown Data by Type (2015-2026)

4.1 Global Antibacterial Therapeutic Historic Market Size by Type (2015-2020)

4.2 Global Antibacterial Therapeutic Forecasted Market Size by Type (2021-2026)

5 Global Antibacterial Therapeutic Breakdown Data by Application (2015-2026)

5.1 Global Antibacterial Therapeutic Historic Market Size by Application (2015-2020)

5.2 Antibacterial Therapeutic Forecasted Market Size by Application (2021-2026)

6 North America

6.1 North America Antibacterial Therapeutic Market Size YoY Growth 2015-2026

6.2 Antibacterial Therapeutic Key Players in North America

6.3 North America Antibacterial Therapeutic Market Size by Type (2015-2020)

6.4 North America Antibacterial Therapeutic Market Size by Application (2015-2020)

7 Europe

7.1 Europe Antibacterial Therapeutic Market Size YoY Growth 2015-2026

7.2 Antibacterial Therapeutic Key Players in Europe

7.3 Europe Antibacterial Therapeutic Market Size by Type (2015-2020)

7.4 Europe Antibacterial Therapeutic Market Size by Application (2015-2020)

8 China

8.1 China Antibacterial Therapeutic Market Size YoY Growth 2015-2026

8.2 Antibacterial Therapeutic Key Players in China

8.3 China Antibacterial Therapeutic Market Size by Type (2015-2020)

8.4 China Antibacterial Therapeutic Market Size by Application (2015-2020)

9 Japan

9.1 Japan Antibacterial Therapeutic Market Size YoY Growth 2015-2026

9.2 Antibacterial Therapeutic Key Players in Japan

9.3 Japan Antibacterial Therapeutic Market Size by Type (2015-2020)

9.4 Japan Antibacterial Therapeutic Market Size by Application (2015-2020)

10 Southeast Asia

10.1 Southeast Asia Antibacterial Therapeutic Market Size YoY Growth 2015-2026

10.2 Antibacterial Therapeutic Key Players in Southeast Asia

10.3 Southeast Asia Antibacterial Therapeutic Market Size by Type (2015-2020)

10.4 Southeast Asia Antibacterial Therapeutic Market Size by Application (2015-2020)

11 India

11.1 India Antibacterial Therapeutic Market Size YoY Growth 2015-2026

11.2 Antibacterial Therapeutic Key Players in India

11.3 India Antibacterial Therapeutic Market Size by Type (2015-2020)

11.4 India Antibacterial Therapeutic Market Size by Application (2015-2020)

12 Central & South America

12.1 Central & South America Antibacterial Therapeutic Market Size YoY Growth 2015-2026

12.2 Antibacterial Therapeutic Key Players in Central & South America

12.3 Central & South America Antibacterial Therapeutic Market Size by Type (2015-2020)

12.4 Central & South America Antibacterial Therapeutic Market Size by Application (2015-2020)

13 Key Players Profiles

13.1 Abbott

13.1.1 Abbott Company Details

13.1.2 Abbott Business Overview and Its Total Revenue

13.1.3 Abbott Introduction

13.1.4 Abbott Revenue in Antibacterial Therapeutic Business (2015-2020)

13.1.5 Abbott Recent Development

13.2 Daiichi Sankyo

13.2.1 Daiichi Sankyo Company Details

13.2.2 Daiichi Sankyo Business Overview and Its Total Revenue

13.2.3 Daiichi Sankyo Introduction

13.2.4 Daiichi Sankyo Revenue in Antibacterial Therapeutic Business (2015-2020)

13.2.5 Daiichi Sankyo Recent Development

13.3 Pfizer

13.3.1 Pfizer Company Details

13.3.2 Pfizer Business Overview and Its Total Revenue

13.3.3 Pfizer Introduction

13.3.4 Pfizer Revenue in Antibacterial Therapeutic Business (2015-2020)

13.3.5 Pfizer Recent Development

13.4 Takeda

13.4.1 Takeda Company Details

13.4.2 Takeda Business Overview and Its Total Revenue

13.4.3 Takeda Introduction

13.4.4 Takeda Revenue in Antibacterial Therapeutic Business (2015-2020)

13.4.5 Takeda Recent Development

13.5 Eli Lilly

13.5.1 Eli Lilly Company Details

13.5.2 Eli Lilly Business Overview and Its Total Revenue

13.5.3 Eli Lilly Introduction

13.5.4 Eli Lilly Revenue in Antibacterial Therapeutic Business (2015-2020)

13.5.5 Eli Lilly Recent Development

13.6 Novartis

13.6.1 Novartis Company Details

13.6.2 Novartis Business Overview and Its Total Revenue

13.6.3 Novartis Introduction

13.6.4 Novartis Revenue in Antibacterial Therapeutic Business (2015-2020)

13.6.5 Novartis Recent Development

13.7 Sanofi

13.7.1 Sanofi Company Details

13.7.2 Sanofi Business Overview and Its Total Revenue

13.7.3 Sanofi Introduction

13.7.4 Sanofi Revenue in Antibacterial Therapeutic Business (2015-2020)

13.7.5 Sanofi Recent Development

13.8 AstraZeneca

13.8.1 AstraZeneca Company Details

13.8.2 AstraZeneca Business Overview and Its Total Revenue

13.8.3 AstraZeneca Introduction

13.8.4 AstraZeneca Revenue in Antibacterial Therapeutic Business (2015-2020)

13.8.5 AstraZeneca Recent Development

13.9 Bayer

13.9.1 Bayer Company Details

13.9.2 Bayer Business Overview and Its Total Revenue

13.9.3 Bayer Introduction

13.9.4 Bayer Revenue in Antibacterial Therapeutic Business (2015-2020)

13.9.5 Bayer Recent Development

13.10 Merck

13.10.1 Merck Company Details

13.10.2 Merck Business Overview and Its Total Revenue

13.10.3 Merck Introduction

13.10.4 Merck Revenue in Antibacterial Therapeutic Business (2015-2020)

13.10.5 Merck Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Disclaimer

Table 1. Antibacterial Therapeutic Key Market Segments

Table 2. Key Players Covered: Ranking by Antibacterial Therapeutic Revenue

Table 3. Ranking of Global Top Antibacterial Therapeutic Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Antibacterial Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Penicillins

Table 6. Key Players of Cephalosporins

Table 7. Key Players of Quinolone

Table 8. Key Players of Aminoglycosides

Table 9. Key Players of Monobactams

Table 10. Key Players of Carbapenems

Table 11. Key Players of Macrolides

Table 12. Key Players of Others

Table 13. COVID-19 Impact Global Market: (Four Antibacterial Therapeutic Market Size Forecast Scenarios)

Table 14. Opportunities and Trends for Antibacterial Therapeutic Players in the COVID-19 Landscape

Table 15. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 16. Key Regions/Countries Measures against Covid-19 Impact

Table 17. Proposal for Antibacterial Therapeutic Players to Combat Covid-19 Impact

Table 18. Global Antibacterial Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 19. Global Antibacterial Therapeutic Market Size by Region (US$ Million): 2020 VS 2026

Table 20. Global Antibacterial Therapeutic Market Size by Regions (2015-2020) (US$ Million)

Table 21. Global Antibacterial Therapeutic Market Share by Regions (2015-2020)

Table 22. Global Antibacterial Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 23. Global Antibacterial Therapeutic Market Share by Regions (2021-2026)

Table 24. Market Top Trends

Table 25. Key Drivers: Impact Analysis

Table 26. Key Challenges

Table 27. Antibacterial Therapeutic Market Growth Strategy

Table 28. Main Points Interviewed from Key Antibacterial Therapeutic Players

Table 29. Global Antibacterial Therapeutic Revenue by Players (2015-2020) (US$ Million)

Table 30. Global Antibacterial Therapeutic Market Share by Players (2015-2020)

Table 31. Global Top Antibacterial Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibacterial Therapeutic as of 2019)

Table 32. Global 5 Largest Players Market Share by Antibacterial Therapeutic Revenue (CR5 and HHI) (2015-2020)

Table 33. Key Players Headquarters and Area Served

Table 34. Key Players Antibacterial Therapeutic Product Solution and Service

Table 35. Date of Enter into Antibacterial Therapeutic Market

Table 36. Mergers & Acquisitions, Expansion Plans

Table 37. Global Antibacterial Therapeutic Market Size by Type (2015-2020) (US$ Million)

Table 38. Global Antibacterial Therapeutic Revenue Market Share by Type (2015-2020)

Table 39. Global Antibacterial Therapeutic Forecasted Market Size by Type (2021-2026) (US$ Million)

Table 40. Global Antibacterial Therapeutic Revenue Market Share by Type (2021-2026)

Table 41. Global Antibacterial Therapeutic Market Size by Application (2015-2020) (US$ Million)

Table 42. Global Antibacterial Therapeutic Revenue Market Share by Application (2015-2020)

Table 43. Global Antibacterial Therapeutic Forecasted Market Size by Application (2021-2026) (US$ Million)

Table 44. Global Antibacterial Therapeutic Revenue Market Share by Application (2021-2026)

Table 45. North America Key Players Antibacterial Therapeutic Revenue (2019-2020) (US$ Million)

Table 46. North America Key Players Antibacterial Therapeutic Market Share (2019-2020)

Table 47. North America Antibacterial Therapeutic Market Size by Type (2015-2020) (US$ Million)

Table 48. North America Antibacterial Therapeutic Market Share by Type (2015-2020)

Table 49. North America Antibacterial Therapeutic Market Size by Application (2015-2020) (US$ Million)

Table 50. North America Antibacterial Therapeutic Market Share by Application (2015-2020)

Table 51. Europe Key Players Antibacterial Therapeutic Revenue (2019-2020) (US$ Million)

Table 52. Europe Key Players Antibacterial Therapeutic Market Share (2019-2020)

Table 53. Europe Antibacterial Therapeutic Market Size by Type (2015-2020) (US$ Million)

Table 54. Europe Antibacterial Therapeutic Market Share by Type (2015-2020)

Table 55. Europe Antibacterial Therapeutic Market Size by Application (2015-2020) (US$ Million)

Table 56. Europe Antibacterial Therapeutic Market Share by Application (2015-2020)

Table 57. China Key Players Antibacterial Therapeutic Revenue (2019-2020) (US$ Million)

Table 58. China Key Players Antibacterial Therapeutic Market Share (2019-2020)

Table 59. China Antibacterial Therapeutic Market Size by Type (2015-2020) (US$ Million)

Table 60. China Antibacterial Therapeutic Market Share by Type (2015-2020)

Table 61. China Antibacterial Therapeutic Market Size by Application (2015-2020) (US$ Million)

Table 62. China Antibacterial Therapeutic Market Share by Application (2015-2020)

Table 63. Japan Key Players Antibacterial Therapeutic Revenue (2019-2020) (US$ Million)

Table 64. Japan Key Players Antibacterial Therapeutic Market Share (2019-2020)

Table 65. Japan Antibacterial Therapeutic Market Size by Type (2015-2020) (US$ Million)

Table 66. Japan Antibacterial Therapeutic Market Share by Type (2015-2020)

Table 67. Japan Antibacterial Therapeutic Market Size by Application (2015-2020) (US$ Million)

Table 68. Japan Antibacterial Therapeutic Market Share by Application (2015-2020)

Table 69. Southeast Asia Key Players Antibacterial Therapeutic Revenue (2019-2020) (US$ Million)

Table 70. Southeast Asia Key Players Antibacterial Therapeutic Market Share (2019-2020)

Table 71. Southeast Asia Antibacterial Therapeutic Market Size by Type (2015-2020) (US$ Million)

Table 72. Southeast Asia Antibacterial Therapeutic Market Share by Type (2015-2020)

Table 73. Southeast Asia Antibacterial Therapeutic Market Size by Application (2015-2020) (US$ Million)

Table 74. Southeast Asia Antibacterial Therapeutic Market Share by Application (2015-2020)

Table 75. India Key Players Antibacterial Therapeutic Revenue (2019-2020) (US$ Million)

Table 76. India Key Players Antibacterial Therapeutic Market Share (2019-2020)

Table 77. India Antibacterial Therapeutic Market Size by Type (2015-2020) (US$ Million)

Table 78. India Antibacterial Therapeutic Market Share by Type (2015-2020)

Table 79. India Antibacterial Therapeutic Market Size by Application (2015-2020) (US$ Million)

Table 80. India Antibacterial Therapeutic Market Share by Application (2015-2020)

Table 81. Central & South America Key Players Antibacterial Therapeutic Revenue (2019-2020) (US$ Million)

Table 82. Central & South America Key Players Antibacterial Therapeutic Market Share (2019-2020)

Table 83. Central & South America Antibacterial Therapeutic Market Size by Type (2015-2020) (US$ Million)

Table 84. Central & South America Antibacterial Therapeutic Market Share by Type (2015-2020)

Table 85. Central & South America Antibacterial Therapeutic Market Size by Application (2015-2020) (US$ Million)

Table 86. Central & South America Antibacterial Therapeutic Market Share by Application (2015-2020)

Table 87. Abbott Company Details

Table 88. Abbott Business Overview

Table 89. Abbott Revenue in Antibacterial Therapeutic Business (2015-2020) (US$ Million)

Table 90. Abbott Product

Table 91. Abbott Recent Development

Table 92. Daiichi Sankyo Company Details

Table 93. Daiichi Sankyo Business Overview

Table 94. Daiichi Sankyo Revenue in Antibacterial Therapeutic Business (2015-2020) (US$ Million)

Table 95. Daiichi Sankyo Product

Table 96. Daiichi Sankyo Recent Development

Table 97. Pfizer Company Details

Table 98. Pfizer Business Overview

Table 99. Pfizer Revenue in Antibacterial Therapeutic Business (2015-2020) (US$ Million)

Table 100. Pfizer Product

Table 101. Pfizer Recent Development

Table 102. Takeda Company Details

Table 103. Takeda Business Overview

Table 104. Takeda Revenue in Antibacterial Therapeutic Business (2015-2020) (US$ Million)

Table 105. Takeda Product

Table 106. Takeda Recent Development

Table 107. Eli Lilly Company Details

Table 108. Eli Lilly Business Overview

Table 109. Eli Lilly Revenue in Antibacterial Therapeutic Business (2015-2020) (US$ Million)

Table 110. Eli Lilly Product

Table 111. Eli Lilly Recent Development

Table 112. Novartis Company Details

Table 113. Novartis Business Overview

Table 114. Novartis Revenue in Antibacterial Therapeutic Business (2015-2020) (US$ Million)

Table 115. Novartis Product

Table 116. Novartis Recent Development

Table 117. Sanofi Company Details

Table 118. Sanofi Business Overview

Table 119. Sanofi Revenue in Antibacterial Therapeutic Business (2015-2020) (US$ Million)

Table 120. Sanofi Product

Table 121. Sanofi Recent Development

Table 122. AstraZeneca Company Details

Table 123. AstraZeneca Business Overview

Table 124. AstraZeneca Revenue in Antibacterial Therapeutic Business (2015-2020) (US$ Million)

Table 125. AstraZeneca Product

Table 126. AstraZeneca Recent Development

Table 127. Bayer Company Details

Table 128. Bayer Business Overview

Table 129. Bayer Revenue in Antibacterial Therapeutic Business (2015-2020) (US$ Million)

Table 130. Bayer Product

Table 131. Bayer Recent Development

Table 132. Merck Company Details

Table 133. Merck Business Overview

Table 134. Merck Revenue in Antibacterial Therapeutic Business (2015-2020) (US$ Million)

Table 135. Merck Product

Table 136. Merck Recent Development

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Antibacterial Therapeutic Market Share by Type in 2020 & 2026

Figure 2. Penicillins Features

Figure 3. Cephalosporins Features

Figure 4. Quinolone Features

Figure 5. Aminoglycosides Features

Figure 6. Monobactams Features

Figure 7. Carbapenems Features

Figure 8. Macrolides Features

Figure 9. Others Features

Figure 10. Global Antibacterial Therapeutic Market Share by Application in 2020 & 2026

Figure 11. Oral Case Studies

Figure 12. Topical Case Studies

Figure 13. Parenteral Case Studies

Figure 14. Others Case Studies

Figure 15. Antibacterial Therapeutic Report Years Considered

Figure 16. Global Antibacterial Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)

Figure 17. Global Antibacterial Therapeutic Market Share by Regions: 2020 VS 2026

Figure 18. Global Antibacterial Therapeutic Market Share by Regions (2021-2026)

Figure 19. China Market Share in Global Market 2015-2026

Figure 20. Porter's Five Forces Analysis

Figure 21. Global Antibacterial Therapeutic Market Share by Players in 2019

Figure 22. Global Top Antibacterial Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibacterial Therapeutic as of 2019)

Figure 23. The Top 10 and 5 Players Market Share by Antibacterial Therapeutic Revenue in 2019

Figure 24. North America Antibacterial Therapeutic Market Size YoY Growth (2015-2026) (US$ Million)

Figure 25. Europe Antibacterial Therapeutic Market Size YoY Growth (2015-2026) (US$ Million)

Figure 26. China Antibacterial Therapeutic Market Size YoY Growth (2015-2026) (US$ Million)

Figure 27. Japan Antibacterial Therapeutic Market Size YoY Growth (2015-2026) (US$ Million)

Figure 28. Southeast Asia Antibacterial Therapeutic Market Size YoY Growth (2015-2026) (US$ Million)

Figure 29. India Antibacterial Therapeutic Market Size YoY Growth (2015-2026) (US$ Million)

Figure 30. Central & South America Antibacterial Therapeutic Market Size YoY Growth (2015-2026) (US$ Million)

Figure 31. Abbott Revenue Growth Rate in Antibacterial Therapeutic Business (2015-2020)

Figure 32. Abbott Total Revenue (US$ Million): 2019 Compared with 2018

Figure 33. Daiichi Sankyo Revenue Growth Rate in Antibacterial Therapeutic Business (2015-2020)

Figure 34. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018

Figure 35. Pfizer Revenue Growth Rate in Antibacterial Therapeutic Business (2015-2020)

Figure 36. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 37. Takeda Revenue Growth Rate in Antibacterial Therapeutic Business (2015-2020)

Figure 38. Takeda Total Revenue (US$ Million): 2019 Compared with 2018

Figure 39. Eli Lilly Revenue Growth Rate in Antibacterial Therapeutic Business (2015-2020)

Figure 40. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018

Figure 41. Novartis Revenue Growth Rate in Antibacterial Therapeutic Business (2015-2020)

Figure 42. Novartis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 43. Sanofi Revenue Growth Rate in Antibacterial Therapeutic Business (2015-2020)

Figure 44. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 45. AstraZeneca Revenue Growth Rate in Antibacterial Therapeutic Business (2015-2020)

Figure 46. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018

Figure 47. Bayer Revenue Growth Rate in Antibacterial Therapeutic Business (2015-2020)

Figure 48. Bayer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 49. Merck Revenue Growth Rate in Antibacterial Therapeutic Business (2015-2020)

Figure 50. Merck Total Revenue (US$ Million): 2019 Compared with 2018

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed